<ѻý>FDA Rejects MDMA-Assisted Therapy for PTSDѻý> Decision largely expected after agency advisors voted against psychedelic's safety and efficacy Aug 09, 2024
<ѻý>FDA Approves First Emergency Allergy Nasal Sprayѻý> Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions Aug 09, 2024
<ѻý>New Extended-Release Parkinson's Drug Approvedѻý> Novel levodopa and carbidopa formulation led to more time without troublesome dyskinesia Aug 08, 2024
<ѻý>IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCLѻý> New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
<ѻý>FDA OKs Complement Inhibitor for IgA Nephropathyѻý> First-in-class iptacopan approved to reduce proteinuria in adults with rare progressive disease Aug 08, 2024
<ѻý>FDA Approves Vorasidenib for IDH-Mutant Gliomasѻý> Treatment improved PFS by 16 months compared with placebo in INDIGO trial Aug 06, 2024
<ѻý>Plant-based Food and Drink Labeling Is a Battlefieldѻý> Public health considerations are missing in action Aug 06, 2024
<ѻý>Prescription-Free Online Semaglutide Is Risky Businessѻý> Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
<ѻý>FDA Advisors Mostly Convinced Arimoclomol Works for Rare Genetic Disorderѻý> If approved, this would be the first drug for Niemann-Pick disease type C Aug 03, 2024
<ѻý>FDA Greenlights First Engineered Cell Therapy for a Solid Tumorѻý> Afamitresgene autoleucel (Tecelra) approved for metastatic synovial sarcoma Aug 02, 2024
<ѻý>FDA Panel to Consider Arimoclomol for Rare Genetic Disorderѻý> This is the second time the drug has been submitted to the FDA for Niemann-Pick disease type C Aug 01, 2024
<ѻý>FDA OKs Subcutaneous Daratumumab Plus VRd for Myelomaѻý> Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
<ѻý>Heavy Metal in Chocolate; Trump 'No Doubt' Hit By Bullet; FDA Cinnamon Warning Growsѻý> Health news and commentary gathered by ѻý staff Jul 31, 2024
<ѻý>Alzheimer's Gets New Galantamine Drugѻý> Newly approved prodrug has dual mechanism of action to improve tolerability Jul 30, 2024
<ѻý>FDA Warns of Overdoses With Compounded Semaglutideѻý> Multi-dose vials pose complications for self-administration Jul 29, 2024
<ѻý>New Monthly Paliperidone Palmitate Injectable OK'd for Schizophreniaѻý> Long-acting intramuscular product approved for schizoaffective disorder as well Jul 29, 2024
<ѻý>FDA Approves Blood Test for Colon Cancer Screeningѻý> Shield becomes the first liquid biopsy for primary CRC screening Jul 29, 2024
<ѻý>Veterans Lobby for Psychedelic Therapy, but Will It Influence MDMA's Approval?ѻý> Hurdles remain for FDA application Jul 27, 2024
<ѻý>Third JAK Inhibitor for Alopecia Areata Wins FDA Approvalѻý> Over 30% of patients had at least 80% scalp hair regrowth with deuruxolitinib Jul 26, 2024
<ѻý>FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trialsѻý> Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
<ѻý>'Shambolic' Medical Meeting; DaVita Whistleblower Suit; FDA Mum on MDMAѻý> This past week in healthcare investigations Jul 24, 2024
<ѻý>FDA OKs First Orally Dissolving Birth Control Pillѻý> Opens up options for people who have trouble swallowing Jul 24, 2024
<ѻý>Trump Talks Cancer Cures, 'Right to Try' as He Accepts GOP Presidential Nominationѻý> "We're going to get to the bottom of it" Jul 19, 2024
<ѻý>FDA Allows Best-Selling E-Cigarette Vuse Alto, but Only in Tobacco Flavorѻý> Agency previously rejected the company's menthol-flavored products Jul 18, 2024
<ѻý>Anti-VEGF Ocular Implant for Age-Related Macular Degeneration to Return to Marketѻý> Updates to device, refill syringe, manufacturing process restore function to expected level Jul 08, 2024
<ѻý>With the End of Chevron, Health and Environmental Experts' Hands Are Tiedѻý> We need the rule of law to protect public health Jul 08, 2024
<ѻý>Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?ѻý> U.S. clinics market oligonucleotide therapy for a wide range of conditions, without much evidence Jul 05, 2024
<ѻý>Supreme Court to Weigh if FDA Was Heavy-Handed With Its Flavored E-Cig Regulationsѻý> Agency is appealing a lower court ruling siding with vaping companies Jul 03, 2024
<ѻý>FDA OKs Another Drug for Early Alzheimer's Diseaseѻý> Decision gives patients a second anti-amyloid treatment option Jul 02, 2024
<ѻý>Supreme Court Decision May Have Sweeping Effects on Healthcare, Experts Sayѻý> Chevron ruling curbs federal power, could upend drug approvals, Medicare drug price negotiation Jul 02, 2024
<ѻý>House Panel OKs Bills on Obesity Drug and Breakthrough Device Coverage in Medicareѻý> Meanwhile, CMS proposed rule on the device coverage, issued a year ago, awaits a final version Jul 01, 2024
<ѻý>FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adultsѻý> Results as quick as 1 hour, enabling a test-and-treat approach Jun 27, 2024
<ѻý>FDA Warns Eye Bank for Taking Donors Who Had Sepsisѻý> All five donors should have been ineligible, FDA said Jun 27, 2024
<ѻý>FDA Approves Novel Nebulized Therapy for COPDѻý> First-in-class dual phosphodiesterase inhibitor lands broad indication for COPD maintenance Jun 27, 2024
<ѻý>Oncology Drug Shortages Persist, but Continue to Evolveѻý> Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
<ѻý>Docs in Abortion Ban States Find Workarounds to Deliver Careѻý> A ѻý survey reveals surprising trends in reproductive care 2 years post-Roe Jun 24, 2024
<ѻý>Subcutaneous C5 Inhibitor Approved for PNHѻý> Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
<ѻý>New Treatment Approved for Chronic Inflammatory Demyelinating Polyneuropathyѻý> Efgartigimod injection reduced CIDP relapse risk Jun 23, 2024
<ѻý>Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancerѻý> KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
<ѻý>Tech in Diabetes: What's Going Wrong?ѻý> FDA Commissioner Robert Califf, MD, talks tech Jun 21, 2024